The director of the Visual Outcomes Laboratory at Cedars Sinai talked about the current treatments used in MS and the risks associated with them at 2023 ACTRIMS Forum. [WATCH TIME: 3 minutes]
Omar Al-Louzi, MD
Advertisement
The director of the Visual Outcomes Laboratory at Cedars Sinai.
Articles by Omar Al-Louzi, MD
Advertisement
Latest Updated Articles
Balancing Efficacy and Safety With MS Disease-Modifying Therapies: Omar Al-Louzi, MDPublished: March 17th 2023 | Updated:
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Parkinson Agent Tavapadon Shows Continued Efficacy, Safety in Phase 3 TEMPO-4 Trial
2
NeurologyLive® Brain Games: October 19, 2025
3
Bilateral MR-Guided Focused Ultrasound Shows Benefit for Managing Parkinson Motor Complications in Phase 3 Trial
4
Ruptured vs Unruptured Aneurysms: Practical Decision Making with Guilherme Dabus, MD
5
